Share on StockTwits

Amgen (NASDAQ:AMGN) saw some unusual options trading activity on Tuesday. Stock investors bought 5,315 put options on the stock, reports. This represents an increase of 217% compared to the typical daily volume of 1,677 put options.

A number of research firms have recently commented on AMGN. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of Amgen in a research note on Tuesday, June 10th. They now have a $140.00 price target on the stock. Finally, analysts at Deutsche Bank reiterated a “buy” rating on shares of Amgen in a research note on Monday, May 12th. Six research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $132.40.

Shares of Amgen (NASDAQ:AMGN) traded up 0.01% on Tuesday, hitting $116.17. The stock had a trading volume of 2,106,136 shares. Amgen has a 1-year low of $95.05 and a 1-year high of $128.96. The stock has a 50-day moving average of $114.1 and a 200-day moving average of $117.. The company has a market cap of $87.943 billion and a price-to-earnings ratio of 18.86.

Amgen (NASDAQ:AMGN) last released its earnings data on Tuesday, April 22nd. The company reported $1.87 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.94 by $0.07. The company had revenue of $4.52 billion for the quarter, compared to the consensus estimate of $4.76 billion. During the same quarter last year, the company posted $1.96 earnings per share. Amgen’s revenue was up 6.7% compared to the same quarter last year. On average, analysts predict that Amgen will post $8.09 earnings per share for the current fiscal year.

Amgen Inc is a global biotechnology pioneer that discovers, develops, manufactures and delivers human therapeutics.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.